Aging increases the cardiotoxicity of daunorubicin and daunorubicinol in the rat

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 51, Issue 5, 1996, Pages

  Cusack, Barry J ^a,b,c   Mushlin, Phillip S ^d   Johnson, Christopher J ^e   Vestal, Robert E ^a,b,c   Olson, Richard D ^a,b,c  

^a Boise VA Medical Center   (United States)

^b St Luke's Mountain States Tumor Institute   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Idaho Department of Health and Welfare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BUFFER; DAUNORUBICIN; DAUNORUBICINOL; SODIUM CHLORIDE;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE MUSCLE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENESCENCE;

ANIMALIA;

EID: 0029832884     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/51A.5.B376     Document Type: Article

References (36)

1. Bachur, N.R.; Gee, G. Microsomal reductive glycosidase J. Pharmacol. Exp Ther. 197:681-686; 1976.
2. Borzak, S.; Murphy, S.; Marsh, J.D. Mechanisms of rate staircase in rat ventricular cells. Am. J Physiol. 260:H884-H892; 1991.
3. Boucek, R.J.; Olson, R.D.; Brenner, D.E.; Ogunbunmi, E.M.; Inui, M.; Fleischer, S. The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps. J. Biol. Chem. 262:15851-15856; 1987.
4. Bristow, M.R.; Mason, J.W.; Billingham, M.E.; Daniels, J.R. Doxorubicin cardiomyopathy; evaluation by phonocardiography, endomyocardial biopsy and cardiac catheterization. Ann. Intern. Med. 88:168-175; 1978.
5. Brown, K.A.; Alton, J.B.; Weiss, R.M.; Stewart, J.A. Acute effects of doxorubicin on human left ventricular systolic and diastolic function. Am. Heart J. 118:979-982, 1989.
6. Capasso, J.M.; Remily, R.M.; Sonnenblick, E.H. Age-related differences in excitation-contraction coupling in rat papillary muscle. Basic Res. Cardiol. 78:492-504; 1983.
7. Colombo, T.;Donelli, M.G.; Urso, R.; Dallarda, S.; Bartosek, I.; Guitani, A Doxorubicin toxicity and pharmacokinetics in old and young rats. Exp. Gerontol. 24:159-171; 1989.
8. Combs, A.B.; Acosta, A.; Ramos, K. Effects of doxorubicin and verapamil on calcium uptake in primary cultures of rat myocardial cells. Biochem. Pharmacol. 34:1115-1116; 1985.
9. Cusack, B.J.; Mushlin, P.S.; Voulelis, L.D.; Li, X.; Boucek, R.J., Jr.; Olson, R.D. Daunorubicin-induced cardiac injury in the rabbit: A role for daunorubicinol? Toxical. Appl. Pharmacol. 118:177-185; 1993.
10. Cusack, B.J.; Young, S.P.; Olson, R.D. Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat. Cancer Chemother. Pharmacol. 35:213-218; 1995.
11. de Jong, J.; Schoofs, P.R.; Snabilié, A.M.; Bast, A.; van der Vijgh, W.J.F. The role of biotransformation in anthracycline-induced cardiotoxicity in mice. J. Pharmacol. Exp. Ther. 266:1312-1320; 1993.
12. Dresdale, A.; Bonow, R.O.; Wesley, R.; Palmeri, S.T.; Barr, L.; Mathison, D.; D'Angelo, T.; Rosenberg, S.A. Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas. Cancer 52:51-60; 1983.
13. Freiss, G.G.; Boyd, J.F.; Geer, M.R.; Garcia, J.C. Effects of first-dose doxorubicin on cardiac rhythm as evaluated by continuous 24-hour monitoring. Cancer 56:2762-2764; 1985.
14. Froehlich, J.P.; Lakatta, E.G.; Beard, E.; Spurgeon, H.A.; Weisfeldt, M.L.; Gerstenbilth, G. Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium. J. Mol. Cell. Cardiol. 10:427-433; 1978.
15. Gervasi, P G.; Agrillo, M.R.; Citti, L.; Danesi, R.; Del Tacca, M. Superoxide anion production by adriamycinol from cardiac sarcosomes and by mitochondrial NADH dehydrogenase. Anticancer Res. 6:1231-1236; 1986.
16. Harada, H.; Cusack, B.J.; Olson, R.D.; Stroo, W.; Azuma, J.; Hamaguchi, T.; Schaffer, S.W. Taurine deficiency and doxorubicin: Interaction with the cardiac sarcolemmal calcium pump. Biochem. Pharmacol 39: 745-751; 1990.
17. Jensen, R.A. Doxorubicin cardiotoxicity: Contractile changes after long-term treatment in the rat. J. Pharmacol. Exp. Ther. 236:197-203; 1986.
18. Jiang, M.T., Narayanan, N. Effects of aging on phospholamban phosphorylation and calcium transport in rat cardiac sarcoplasmic reticulum. Mech. Ageing Dev. 54:87-101; 1990
19. Kim, D.H.; Landry, A.B.; Lee, Y.S.; Katz, K.M. Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. J. Mol. Cell. Cardiol. 21:433-436; 1989.
20. 2+ oscillations. Circulation 68:111-116; 1983.
21. Mushlin, P.S.; Cusack, B.J.; Boucek, R.J., Jr.; Andrejuk, T.; Xuande, L.; Olson, R.D. Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function. Br. J. Pharmacol. 110:975-982; 1993.
22. Narayanan, N. Differential alterations in ATP-supported calcium transport activities of sarcoplasmic reticulum and sarcolemma of aging myocardium. Biochem. Biophys. Acta 678:442-459; 1981.
23. Olson, R.D.; Brenner, D.E.; Cusack, B.J.; Mushlin, P.S.; Andrejuk, T.; Boucek, R.J. Effect of daunorubicinol on myocardial function. Proc. Am. Assoc. Cancer Res. 28:441 (Abst), 1987.
24. Olson, R.D.; Mushlin, P.S.; Brenner, D.E.; Fleischer, S.; Cusack, B.J.; Change, B.K., Boucek, R.J , Jr. Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol Proc. Natl. Acad. Sci. 85:3585-3589; 1988.
25. Orchard, C.H.; Lakatta, E.G. Intracellular calcium transients and developed tension in rat heart muscle. A mechanism for the negative intervalstrength relationship. J. Gen. Physiol. 86:637-651; 1985.
26. Palmeri, S.T.; Borrow, R.O.; Myers, C.E.; Seipp, C.; Jenkins, J.; Green, M.V.; Bacharach, S.L.; Rosenberg, S.A. Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionucleide angiography. Am. J. Cardiol. 58:607-613; 1986.
27. 2+ release from rat cardiac sarcoplasmic reticulum: Possible receptor-mediated mechanism of doxorubicin cardiomyopathy. Mol. Pharmacol. 37:503-514; 1989.
28. Saman, S.; Jacobs, P.; Opie, L.H. Mechanism of acute anthracycline cardiotoxicity in isolated rat hearts: Carminomycin versus daunomycin. Cancer Res. 44:1316-1320; 1984.
29. 2+ exchange in the force-frequency relationships of rat heart muscle. J. Mol. Cell. Cardiol. 23:1039-1050; 1991.
30. Stemmer, P.; Akera, T. Concealed positive force-frequency relationships in rat and mouse cardiac muscle revealed by ryanodine. Am. J. Physiol. 251:H1106-H1110; 1986.
31. Unverferth, D.V.; Majorien, R.D.; Unverferth, B.P.; Talley, R.L.; Balcerzak, S.P.; Baba. N. Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration. Cancer Treat. Rep. 65 1093-1097; 1981.
32. Von Hoff, D.D.; Layard, M.W.; Basa, P.; Davis, H.L.; Von Hoff, A.L.; Rozenweig, M.K.; Muggie, F.M. Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med. 91:710-717; 1979.
33. Wei, J.Y.; Spurgeon, H.A.; Lakatta, E.G. Excitation-contraction in rat myocardium: alterations with adult aging. Am. J. Physiol. 246:H784-H791; 1984.
34. Weinberg, L.E.; Singal, R.K. Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in rats. Can. J. Physiol. Pharmacol. 65:1957-1965; 1987.
35. Willerson, J.T.; Wheeler, S.; Adcock, R.C.; Templeton, G.H. Species differences in responses to hyperosmolality and D600 in cat and rat heart. Am. J. Physiol. 235:H276-H280; 1978.
36. Wortman, J.E.; Lucas, V J.; Shuster, E.; Thiele, D.; Logue, G.L. Sudden death during doxorubicin administration Cancer 44:1588-1591; 1979.